Literature DB >> 24231660

A within-patient analysis for time-varying risk factors of CKD progression.

Liang Li1, Alexander Chang, Stephen G Rostand, Lee Hebert, Lawrence J Appel, Brad C Astor, Michael S Lipkowitz, Jackson T Wright, Cynthia Kendrick, Xuelei Wang, Tom H Greene.   

Abstract

Recent data suggest that nonlinear GFR trajectories are common among patients with CKD, but the modifiable risk factors underlying these changes in CKD progression rate are unknown. Analyses relating baseline risk factors to subsequent GFR decline are suboptimal because these relationships often attenuate as follow-up time increases and these analyses do not account for temporal changes in risk factors. We identified 74 participants in the African American Study of Kidney Disease and Hypertension who had both a period of rapid GFR decline and an extended period of stability during a follow-up period of ≥12 years. We performed a within-patient comparison of time-varying risk factors measured during the periods of GFR decline and stability and identified several risk factors associated with faster GFR decline: more hospitalization episodes and hospitalization days per year; higher BP, serum phosphorus, and urine protein-to-creatinine ratio; lower serum albumin and urine sodium-to-potassium ratio; slower rate of decline of serum urea nitrogen, serum creatinine, serum uric acid, and serum phosphorus; and faster rate of decline of serum hematocrit and serum bicarbonate. By allowing each patient to serve as his or her own control, this novel, within-patient analytic approach holds considerable promise as a means to identify time-varying risk factors associated with stabilization of GFR or acceleration of GFR decline.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24231660      PMCID: PMC3935589          DOI: 10.1681/ASN.2013050464

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  26 in total

1.  Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Authors:  Tilman B Drüeke; Francesco Locatelli; Naomi Clyne; Kai-Uwe Eckardt; Iain C Macdougall; Dimitrios Tsakiris; Hans-Ulrich Burger; Armin Scherhag
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

2.  Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy.

Authors:  Ashutosh Mahajan; Jan Simoni; Simon J Sheather; Kristine R Broglio; M H Rajab; Donald E Wesson
Journal:  Kidney Int       Date:  2010-05-05       Impact factor: 10.612

3.  Bicarbonate supplementation slows progression of CKD and improves nutritional status.

Authors:  Ione de Brito-Ashurst; Mira Varagunam; Martin J Raftery; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

4.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

5.  Serum bicarbonate levels and the progression of kidney disease: a cohort study.

Authors:  Samir N Shah; Matthew Abramowitz; Thomas H Hostetter; Michal L Melamed
Journal:  Am J Kidney Dis       Date:  2009-04-25       Impact factor: 8.860

6.  The rationale and design of the AASK cohort study.

Authors:  Lawrence J Appel; John Middleton; Edgar R Miller; Michael Lipkowitz; Keith Norris; Lawrence Y Agodoa; George Bakris; Janice G Douglas; Jeanne Charleston; Jennifer Gassman; Tom Greene; Kenneth Jamerson; John W Kusek; Julia A Lewis; Robert A Phillips; Stephen G Rostand; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

7.  Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.

Authors:  William F Keane; Zhongxin Zhang; Paulette A Lyle; Mark E Cooper; Dick de Zeeuw; Jean-Pierre Grunfeld; James P Lash; Janet B McGill; William E Mitch; Giuseppe Remuzzi; Shahnaz Shahinfar; Steven M Snapinn; Robert Toto; Barry M Brenner
Journal:  Clin J Am Soc Nephrol       Date:  2006-05-17       Impact factor: 8.237

8.  Uric acid and long-term outcomes in CKD.

Authors:  Magdalena Madero; Mark J Sarnak; Xuelei Wang; Tom Greene; Gerald J Beck; John W Kusek; Allan J Collins; Andrew S Levey; Vandana Menon
Journal:  Am J Kidney Dis       Date:  2009-03-20       Impact factor: 8.860

9.  End-stage renal disease preceded by rapid declines in kidney function: a case series.

Authors:  Peter Lee; Kirsten Johansen; Chi-yuan Hsu
Journal:  BMC Nephrol       Date:  2011-02-01       Impact factor: 2.388

10.  Acute kidney injury increases risk of ESRD among elderly.

Authors:  Areef Ishani; Jay L Xue; Jonathan Himmelfarb; Paul W Eggers; Paul L Kimmel; Bruce A Molitoris; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2008-11-19       Impact factor: 14.978

View more
  14 in total

1.  Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.

Authors:  Godela M Brosnahan; Kaleab Z Abebe; Charity G Moore; Frederic F Rahbari-Oskoui; Kyongtae T Bae; Jared J Grantham; Robert W Schrier; William E Braun; Arlene B Chapman; Michael F Flessner; Peter C Harris; Marie C Hogan; Ronald D Perrone; Dana C Miskulin; Theodore I Steinman; Vicente E Torres
Journal:  Am J Kidney Dis       Date:  2018-01-03       Impact factor: 8.860

2.  Stochastic dynamic models and Chebyshev splines.

Authors:  Ruzong Fan; Bin Zhu; Yuedong Wang
Journal:  Can J Stat       Date:  2014-12-01       Impact factor: 0.875

3.  Landmark Linear Transformation Model for Dynamic Prediction with Application to a Longitudinal Cohort Study of Chronic Disease.

Authors:  Yayuan Zhu; Liang Li; Xuelin Huang
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2018-12-23       Impact factor: 1.864

4.  Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.

Authors:  Casey M Rebholz; Morgan E Grams; Kunihiro Matsushita; Lesley A Inker; Meredith C Foster; Andrew S Levey; Elizabeth Selvin; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-30       Impact factor: 8.237

5.  Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.

Authors:  Stephen Zewinger; Thomas Rauen; Michael Rudnicki; Giuseppina Federico; Martina Wagner; Sarah Triem; Stefan J Schunk; Ioannis Petrakis; David Schmit; Stefan Wagenpfeil; Gunnar H Heine; Gert Mayer; Jürgen Floege; Danilo Fliser; Hermann-Josef Gröne; Thimoteus Speer
Journal:  J Am Soc Nephrol       Date:  2018-10-02       Impact factor: 10.121

Review 6.  High serum creatinine nonlinearity: a renal vital sign?

Authors:  Carlos E Palant; Lakhmir S Chawla; Charles Faselis; Ping Li; Thomas L Pallone; Paul L Kimmel; Richard L Amdur
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

7.  Dietary Potassium Intake and Risk of Chronic Kidney Disease Progression in Predialysis Patients with Chronic Kidney Disease: A Systematic Review.

Authors:  Kelly Picard; Maria Ines Barreto Silva; Diana Mager; Caroline Richard
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

8.  Dynamic prediction of time to a clinical event with sparse and irregularly measured longitudinal biomarkers.

Authors:  Yayuan Zhu; Xuelin Huang; Liang Li
Journal:  Biom J       Date:  2020-03-20       Impact factor: 2.207

Review 9.  Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines?

Authors:  Giorgina Barbara Piccoli; Irene Capizzi; Federica Neve Vigotti; Filomena Leone; Claudia D'Alessandro; Domenica Giuffrida; Marta Nazha; Simona Roggero; Nicoletta Colombi; Giuseppe Mauro; Natascia Castelluccia; Adamasco Cupisti; Paolo Avagnina
Journal:  BMC Nephrol       Date:  2016-07-08       Impact factor: 2.388

10.  Patterns of progression of chronic kidney disease at later stages.

Authors:  Fernando Caravaca-Fontán; Lilia Azevedo; Enrique Luna; Francisco Caravaca
Journal:  Clin Kidney J       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.